Takeda: all 1,753 studies

Page 10 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKDCompletedNCT01128179Phase 2Results posted
• Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry DiseaseCompletedNCT01124643Phase 3Results posted
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative ColitisCompletedNCT01124149Phase 4Results posted
• Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced ConstipationTerminatedNCT01117051Phase 3Results posted
• Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateCompletedNCT01106430Phase 3Results posted
• Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)CompletedNCT01101035Phase 3Results posted
• Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01101022Phase 4Results posted
• Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH)CompletedNCT01099215Phase 1/2Results posted
• IGF-1/IGFBP3 Prevention of Retinopathy of PrematurityCompletedNCT01096784Phase 2Results posted
• Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep LossCompletedNCT01096680Phase 2Results posted
• CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12CompletedNCT01095510Phase 2Results posted
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE AdministrationCompletedNCT01095497Phase 2Results posted
• A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel RegimenCompletedNCT01094288Phase 1Results posted
• Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerCompletedNCT01091428Phase 2Results posted
• Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01084655Phase 1/2Results posted
• Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)CompletedNCT01084278Phase 4Results posted
• Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal ImpairmentCompletedNCT01082640Phase 2Results posted
• Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)CompletedNCT01081145Phase 3Results posted
• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HClCompletedNCT01081132Phase 3Results posted
• Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early GoutCompletedNCT01078389Phase 2Results posted
• A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy AdultsTerminatedNCT01078376Phase 1Results posted
• Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate StonesCompletedNCT01077284Phase 2Results posted
• Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary AngioedemaCompletedNCT01059526Results posted
• Dose Escalation Study of MLN0128 in Participants With Advanced MalignanciesCompletedNCT01058707Phase 1Results posted
• A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)CompletedNCT01047306Results posted
• Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal MalignanciesCompletedNCT01045421Phase 1/2Results posted
• Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT01045096Phase 1Results posted
• Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell LymphomaCompletedNCT01040871Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedNCT01033071Phase 3Results posted
• Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesCompletedNCT01023581Phase 3Results posted
• Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT01010750Phase 1Results posted
• C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksCompletedNCT01005888Phase 3Results posted
• Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)CompletedNCT00997984Phase 3Results posted
• EASSI - Evaluation of the Safety of Self-Administration With IcatibantCompletedNCT00997204Phase 3Results posted
• Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedNCT00996281Phase 3Results posted
• Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 YearsCompletedNCT00994760Results posted
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCompletedNCT00985725Phase 2Results posted
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeCompletedNCT00968708Phase 3Results posted
• Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple MyelomaCompletedNCT00963820Phase 1Results posted
• Study of MLN8237 in Participants With Advanced Solid TumorsCompletedNCT00962091Phase 1Results posted
• Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusCompletedNCT00957268Phase 1Results posted
• Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for InjectionCompletedNCT00952822Phase 1Results posted
• A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.CompletedNCT00942175Phase 1Results posted
• Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®CompletedNCT00937794Results posted
• Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple MyelomaCompletedNCT00932698Phase 1Results posted
• Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma PatientsCompletedNCT00931918Phase 2Results posted
• Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)CompletedNCT00930644Phase 3Results posted
• A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)CompletedNCT00926185Phase 2Results posted
• The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCompletedNCT00925704Phase 1Results posted
• Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsCompletedNCT00922272Phase 2Results posted
• A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®CompletedNCT00920647Phase 1/2Results posted
• A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy VolunteersCompletedNCT00919867Phase 1Results posted
• Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia ACompletedNCT00916032Phase 4Results posted
• Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal InsufficiencyCompletedNCT00915343Phase 2/3Results posted
• A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZECompletedNCT00914966Phase 4Results posted
• Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy AdultsCompletedNCT00914862Phase 1Results posted
• A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)CompletedNCT00912093Phase 3Results posted
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCompletedNCT00905424Phase 2Results posted
• A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy VolunteersCompletedNCT00901576Phase 1Results posted
• A Study of IXAZOMIB in Adult Patients With LymphomaCompletedNCT00893464Phase 1Results posted
• An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome PatientsCompletedNCT00882921Results posted
• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic ConjunctivitisCompletedNCT00882687Phase 2Results posted
• Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy AdultsCompletedNCT00880750Phase 1Results posted
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00877487Phase 4Results posted
• Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCompletedNCT00875017Phase 1Results posted
• Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry DiseaseCompletedNCT00864851Phase 3Results posted
• Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00856284Phase 3Results posted
• MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal CarcinomaCompletedNCT00853307Phase 2Results posted
• Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer InhibitorCompletedNCT00851721Phase 3Results posted
• Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With RituximabTerminatedNCT00850499Phase 2Results posted
• Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCompletedNCT00847808Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00847626Phase 3Results posted
• Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCompletedNCT00847210Phase 1Results posted
• Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00846365Phase 3Results posted
• A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT00830869Phase 1Results posted
• A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic SyndromeCompletedNCT00830518Phase 2Results posted
• Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep DisordersCompletedNCT00830115Results posted
• Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux DiseaseCompletedNCT00829738Results posted
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00818883Phase 3Results posted
• A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseCompletedNCT00818662Phase 3Results posted
• Gammagard Liquid and rHuPH20 in PIDCompletedNCT00814320Phase 3Results posted
• Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's LymphomaCompletedNCT00807495Phase 2Results posted
• Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) SubjectsCompletedNCT00798967Phase 3Results posted
• An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00790933Phase 3Results posted
• Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory DrugsCompletedNCT00787254Phase 3Results posted
• Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17CompletedNCT00784654Phase 3Results posted
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT00783718Phase 3Results posted
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00783692Phase 3Results posted
• Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral SolutionTerminatedNCT00776555Phase 1Results posted
• Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.CompletedNCT00770653Phase 3Results posted
• Vyvanse Adolescent Open-Label Safety and Efficacy Extension StudyCompletedNCT00764868Phase 3Results posted
• Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17CompletedNCT00763971Phase 3Results posted
• A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersTerminatedNCT00762359Phase 3Results posted
• Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic EsophagitisCompletedNCT00762073Phase 2Results posted
• Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCompletedNCT00760214Phase 3Results posted
• Safety and Efficacy Study of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00756002Phase 3Results posted
• Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.CompletedNCT00755846Phase 2Results posted
• Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.CompletedNCT00752791Phase 2Results posted
• Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.CompletedNCT00752609Phase 2Results posted
• Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTCCompletedNCT00746733Phase 1Results posted

← Takeda overview and focus areas